Apt Medical Inc. (688617.SH) announced that its wholly-owned subsidiary, Hunan Apt Medical Co., Ltd., has obtained a medical device registration certificate for its product named Polyvinyl Alcohol Embolic Microspheres. This product is intended for the embolization treatment of hypervascular solid organ malignancies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.